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Children with trisomy 21 (Down syndrome, DS) are pre-
disposed to develop acute megakaryoblastic leukemia
(DS-AMKL) as well as the antecedent transient leukemia
(DS-TL). Mutations in the transcription factor GATA1
have been found in nearly all children with DS-AMKL
and DS-TL, but not in other malignancies. Recent whole
genome sequencing efforts suggested that the interplay
of trisomy 21 and GATA1s-mutation is sufficient to
cause DS-TL.
To decipher the deregulated oncogenic gene network on
hsa21, we conducted a lentiviral shRNA-based viability
screening using GATA1s-mutated DS-AMKL cell line
CMK as well as non-DS-AML cell lines (K562, M-07).
Knock-down of 42 genes conferred a profound selective
growth disadvantage in DS-AMKL cell lines. 31 candidate
genes are located in chromosomal region 21q22.1-
21q22.3. 11 (out of 14 tested) were overexpressed in
DS-AMKL compared to non-DS-AMKL. A secondary
functional validation screening revealed that the potential
oncogenes participate in different cellular processes affect-
ing proliferation, cell viability, apoptosis or differentiation.
To further delineate the impact of 11 selected candidates
on normal hematopoiesis, we characterized their effects in
gain- and loss-of-function studies using CD34+ hemato-
poietic stem and progenitor cells (HSPCs). Knockdown of
four genes (USP25, BACH1, U2AF1 and C21orf33) inhib-
ited megakaryocytic and erythroid in vitro differentiation,
while enhancing myeloid differentiation. The myeloid
differentiation bias was also observed for ATP5O and
C21orf45. The opposite effect was observed in gain-of-
function studies. Ectopic expression of six genes (U2AF1,
C21orf33, IFNGR2, WDR4 or GABPA) resulted in a switch
from erythroid to megakaryocytic differentiation.
Thus, we propose a complex interactive network located
on hsa21. Deregulation of this network might result in
synergistic effects on hematopoietic differentiation,
which promotes transformation of GATA1s-mutated fetal
hematopoietic progenitor cells.
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